Judge’s Ruling Raises Stakes of Teva Pharmaceuticals FCA Case to Almost $12 Billion

Law360 – By framing the terms of the case more favorably to the government, a district court judge has increased Teva Pharmaceutical's vulnerability to nearly $12 billion in FCA damages, for allegedly paying Medicare patients kickbacks to use its multiple sclerosis treatment.